• Policy
• Only 40% of asthma pts undergo Pulmonary function testing
• by Lee, Tak-Sun May 6, 2022 05:46am

• Policy
• New cost of Tecentriq is 2,271,109 won
• by Kim, Jung-Ju May 2, 2022 06:02am

• Policy
• Combi of HBP+ Hyperlipidemia will be released again
• by Lee, Tak-Sun Apr 29, 2022 05:41am

• Policy
• Reviewing the removal of outdoor masks
• by Lee, Jeong-Hwan Apr 28, 2022 06:06am

• Policy
• The transition team operates biohealth regulatory sandboxes
• by Kang, Shin-Kook Apr 27, 2022 06:03am

• Policy
• Betamethasone's permission change is expected
• by Lee, Hye-Kyung Apr 27, 2022 06:03am

• Policy
• Phase III for development of Alecensa & Keytruda
• by Lee, Hye-Kyung Apr 26, 2022 06:11am

• Policy
• Exclude drugs that have increased due to COVID-19 from PVA
• by Lee, Tak-Sun Apr 25, 2022 06:08am

• Policy
• Boryung’s Gemzar switches to domestic production
• by Lee, Hye-Kyung Apr 25, 2022 06:07am

• Policy
• Chong Kun Dang salt modified Entresto will be released soon
• by Lee, Hye-Kyung Apr 25, 2022 06:07am